Successful Treatment of T Cell-Mediated Acute Rejection with Delayed CTLA4-Ig in Mice

Clinical observations that kidney transplant recipients receiving belatacept who experienced T cell-mediated acute rejection can be successfully treated and subsequently maintained on belatacept-based immunosuppression suggest that belatacept is able to control memory T cells. We recently reported t...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, James S., Khiew, Stella H.-W., Yang, Jinghui, Vannier, Augustin, Yin, Dengping, Sciammas, Roger, Alegre, Maria-Luisa, Chong, Anita S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609110/
https://www.ncbi.nlm.nih.gov/pubmed/28970838
http://dx.doi.org/10.3389/fimmu.2017.01169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609110/
https://www.ncbi.nlm.nih.gov/pubmed/28970838
http://dx.doi.org/10.3389/fimmu.2017.01169

Ejemplares similares